Learning Objectives:

1. Describe classes and mechanism of action of immune check-point inhibitors.

2. Review most common immune-related adverse events (IrAEs).

3. Review current research on autoantibody positivity and IrAEs.

Session date: 
06/15/2021 - 8:30am to 9:30am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Marco Lopez-Velazquez, M.D.